Table 2.

Comparison of systemic symptoms between OAB and controls (adjusted for age and sex)

	OAB	Controls	p-value, adjusted for age and sex (OAB vs. controls)	OAB with widespread systemic symptoms	OAB without widespread systemic symptoms	p-value, adjusted for age and sex (with vs. without systemic symptoms)
No. of subjects	51	30		16	35
Systemic symptoms: (mean ± SD)
No. of symptoms checked on the PSPS-Q (up to 59)	17.5 ± 12.3	6.4 ± 7.9	<0.001*	32.0 ± 4.5	10.8 ± 8.2	<0.001*
% of subjects with widespread systemic symptoms	31.4% (n=16)	6.7% (n=2)	0.027*	100%	0%
No. of symptoms in each organ system group: (mean ± SD)
Neurological	4.6 ± 3.5	1.2 ± 1.6	<0.001*	8.3 ± 2.2	2.9 ± 2.6	<0.001*
Cardiopulmonary	1.4 ± 1.4	0.5 ± 1.0	0.004*	2.5 ± 1.5	0.9 ± 1.1	<0.001*
Gastrointestinal	4.0 ± 3.4	1.2 ± 2.1	<0.001*	7.6 ± 1.5	2.3 ± 2.6	<0.001*
Gynecological (females only)	1.9 ± 1.7	1.0 ± 0.9	0.017*	2.6 ± 1.4	1.4 ± 1.7	0.042*
Sexual	1.0 ± 1.1	0.4 ± 0.9	0.027*	2.1 ± 1.3	0.6 ± 0.8	<0.001*
Musculoskeletal	2.1 ± 1.5	0.9 ± 1.3	0.001*	3.6 ± 1.2	1.4 ± 1.1	<0.001*
Psychiatric	3.0 ± 3.1	1.7 ± 2.7	0.085	5.7 ± 2.4	1.8 ± 2.6	<0.001*

^*p<0.05